Lung Cancer News Update

Lung Cancer Rates Are Soaring Among Unlikely Groups — an Oncologist Explains Why “When many people think of an average lung cancer patient, they often imagine an older man smoking. But the face of lung cancer has changed. Over the past 15 years, more women, never smokers, and younger people have been diagnosed with lung cancer.” Annual Lung Cancer Screening Adherence Poor After Initial Screening, Study Finds “Adherence to annual lung cancer screening (LCS) with low-dose CT (LDCT) imaging was only 22.3% among more than 1 million patients who underwent baseline screening between 2015 and 2019, according to study findings published in CHEST.I” University of Houston AI Project Aims to Improve Lung Cancer Diagnostics “The new project will develop a framework for radiologists to collaborate with artificial intelligence systems to enhance lung cancer diagnosis.” Merck Announces Phase 3 KEYNOTE-671 Trial Met Primary Endpoint of Event-Free Survival (EFS) in Patients With Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer “In pivotal study, KEYTRUDA® (pembrolizumab) in combination with chemotherapy before surgery and continuing as a single agent after surgery showed a statistically significant improvement in EFS versus pre-operative chemotherapy.” Trial of Plinabulin, Keytruda, Docetaxel Kicks Off in Lung Cancer “The first patient was enrolled in the phase 2 clinical trial investigating plinabulin plus Keytruda (pembrolizumab) and docetaxel in patients with previously treated non-small cell lung cancer (NSCLC) whose disease got worse after immunotherapy (PD-1 or PD-L1 inhibitors) with or without platinum-doublet chemotherapy, according to BeyondSpring, the manufacturer of plinabulin.” Living in the ‘Granite State’ means elevated risk for radon exposure, and in turn, lung cancer “New Hampshire may be celebrated as the “Granite State,” but the centuries-old nickname also bears caution.” Video: Traveling Through the Lung Cancer Treatment Paradigm: Managing irAEs With Corticosteroids “In this fourth episode of OncChats: Traveling Through the Lung Cancer Treatment Paradigm, Aaron Franke, MD, discusses the management of immune-related adverse effects and the goal of mitigating steroid use for patients with lung cancer.” Special Feature: Join host Hildy Grossman, singer, producer and President of Upstage Lung Cancer and her co-host, WBZ radio’s Jordan Rich on the Backstage @ Upstage podcast. Episodes feature guests in the entertainment, medical and research community, discussing pertinent, inspiring and joyful topics. The latest episode, Wending Her Way to Wellness features Susan Smedley, Founder, Resilient Souls. Susan discusses her process of transitioning from the shock of learning she had lung cancer at such an early age, with an 11-month-old child, to looking for healthy ways to cope using mindfulness, joining advocacy efforts and now creating her own organization to focus on wellness. Listen to Backstage @ Upstage now at upstagelungcancer.org/podcasts and on all podcast platforms.